On 06 August 2020
Alembic Pharmaceuticals announced that a meeting of the Fund Raising Committee of the board of the directors of the Company is scheduled on 06 August 2020 to consider and approve the issue price, including a discount, if any, thereto as permitted under the SEBI ICDR Regulations, for the Equity Shares to be allotted to qualified institutional buyers, pursuant to the Issue.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)